STAAR Surgical Company
General ticker "STAA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.1B (TTM average)
STAAR Surgical Company follows the US Stock Market performance with the rate: 43.9%.
Estimated limits based on current volatility of 1.5%: low 25.74$, high 26.50$
Factors to consider:
- Total employees count: 1211 as of 2024
- US accounted for 6.3% of revenue in the fiscal year ended 2024-12-27
- Top business risk factors: Geopolitical risks, Operational and conduct risks, Regulatory and compliance, Labor/talent shortage/retention, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-27 to 2026-12-27
- 2024-12-27 to 2025-12-27 estimated range: [13.45$, 30.75$]
- 2025-12-27 to 2026-12-27 estimated range: [14.70$, 32.08$]
Financial Metrics affecting the STAA estimates:
- Positive: with PPE of 94.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 77.98 > 63.39
- Negative: negative Net income
- Negative: Investing cash flow per share per price, % of -4.90 <= -4.48
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Inventory ratio change, % of 2.30 > 0.84
- Positive: -8.75 < Industry operating profit margin (median), % of -8.15
Short-term STAA quotes
Long-term STAA plot with estimates
Financial data
| YTD | 2022-12-30 | 2023-12-29 | 2024-12-27 |
|---|---|---|---|
| Operating Revenue | $284.39MM | $322.42MM | $313.90MM |
| Operating Expenses | $240.59MM | $294.32MM | $326.51MM |
| Operating Income | $43.80MM | $28.10MM | $-12.61MM |
| Non-Operating Income | $1.75MM | $5.60MM | $3.56MM |
| R&D Expense | $35.98MM | $44.40MM | $53.97MM |
| Income(Loss) | $45.55MM | $33.70MM | $-9.05MM |
| Taxes | $6.80MM | $12.35MM | $11.16MM |
| Profit(Loss)* | $39.66MM | $21.35MM | $-20.21MM |
| Stockholders Equity | $332.19MM | $385.95MM | $397.33MM |
| Inventory | $24.16MM | $35.13MM | $43.30MM |
| Assets | $414.90MM | $488.69MM | $509.52MM |
| Operating Cash Flow | $35.72MM | $14.59MM | $15.72MM |
| Capital expenditure | $18.11MM | $18.19MM | $23.39MM |
| Investing Cash Flow | $-156.38MM | $74.35MM | $-59.22MM |
| Financing Cash Flow | $8.30MM | $7.42MM | $5.72MM |
| Earnings Per Share** | $0.83 | $0.44 | $-0.41 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.